Skip to main content

Table 4 Repigmentation in the active group for each anatomical site per participant

From: Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy)

 

Anatomical site

Face/neck

Trunk

Upper limbs

Lower limbs

Hands/feet

Number of participants*

6

6

13

11

3

Repigmentation:

Negative–0%

2 (33%)

3 (50%)

3 (22%)

2 (18%)

0

1–24%

1 (17%)

2 (33%)

8 (62%)

7 (64%)

2 (67%)

25–49%

1 (17%)

0

1 (8%)

2 (18%)

1 (33%)

50–74%

0

0

0

0

0

75–100%

2 (33%)

1(17%)

1 (8%)

0

0

Baseline: mean lesion size (cm2 ± SD)

75.4 ± 7.4

13 ± 15.9

11.2 ± 10.9

21 ± 29.1

18.9 ± 25.7

16 week: mean lesion size (cm2 ± SD)

47.4 ± 4.4

13.7 ± 17.4

10.3 ± 9.6

20.6 ± 25.8

22.6 ± 26.6

  1. *One lesion per anatomical site per participant was analysed. If two or more lesions were available on the same anatomical site, the lesion on the right side was chosen. If no lesions were available on the right side, then the lesion, which repigmented the most, was included in the analysis.